Fortive account plan
Industrial technology innovation and solutions
At a glance
Fortive makes instrumentation, software and services for industrial safety, facilities and healthcare, with $4,159.1 million of FY2025 sales.
Fortive, based in Everett, Washington, designs and sells instruments, software and services under brands such as Fluke, ServiceChannel, Gordian, Accruent, Industrial Scientific, ASP and Provation, for maintenance technicians, facility managers, safety professionals and hospitals. After spinning off Ralliant on June 28, 2025, it reports two segments, Intelligent Operating Solutions and Advanced Healthcare Solutions. FY2025 sales from continuing operations were $4,159.1 million (+1.7% core), with an operating margin of 17.3% and net earnings from continuing operations of $532.7 million; approximately 44% of sales came from outside the United States. It has more than 10,000 people in approximately 50 countries and is listed on the NYSE (FTV).
Business units
Intelligent Operating Solutions (IOS)
about 69% of FY2025 sales ($2,856.3 million)Professional instruments (Fluke), facility and asset lifecycle software (ServiceChannel, Gordian, Accruent) and connected worker safety and gas detection (Industrial Scientific, Intelex), for industrial, energy, retail and government customers. FY2025 operating margin was 25.8%, and Q3 2026 core growth accelerated to 9.1% with a 29.1% margin.
Advanced Healthcare Solutions (AHS)
about 31% of FY2025 sales ($1,302.8 million)Instrument sterilization (ASP), instrument tracking (Censis), biomedical test tools (Fluke Biomedical), dosimetry (Landauer) and clinical productivity software (Provation) for healthcare providers. Sales grew 0.8% core in 2025 as U.S. hospitals deferred capital spending; Q3 2026 sales were $340.4 million with an 11.2% operating margin.
Strategic priorities
- Fortive Accelerated
- The strategy is to accelerate profitable organic growth through the Fortive Business System, now infused with AI and machine learning, allocate capital with discipline and build investor trust.
- Data centers for Fluke
- Data centers are a Fluke growth priority, still "low single digits" of Fortive revenue, with deep discovery with hyperscalers and added sales capacity.
- AI in mission-critical software
- AI-powered asset recognition and agents at ServiceChannel, iNet Insights at Industrial Scientific and voice documentation at Provation.
- Set up AHS for multiyear growth
- 2026 is a year of "deliberate and time-bounded investments" in the AHS installed base, ambulatory surgical centers and innovation.
- Recurring revenue
- Management invests in "more recurring customer value"; Fluke's recurring revenue grew double-digit ARR.
Latest results
In Q3 2026 (quarter ended October 2, 2026), sales were $1,107.5 million, up 7.8% reported and 7.2% core, with operating margin of 21.3% versus 15.5% a year earlier, partly from IEEPA tariff refunds. Adjusted EBITDA was $339M (+9.5%) and adjusted diluted EPS $0.77 (+13.2%). IOS led with 9.1% core growth while AHS grew 3.1% core. Fortive raised FY2026 adjusted EPS guidance to $3.10-$3.14 and expects reported revenue "just north of $4.4 billion" with core growth "just north of 5%".
Investments and deals
- Share buybacks
- 30 million shares repurchased for about $1.61 billion in 2025 and 17.2 million shares for about $1.0 billion in the first nine months of 2026; ~$2.3 billion since the launch of new Fortive.
- Bolt-on acquisitions
- A majority stake in a bolt-on AHS business for €51 million in June 2026; bolt-ons such as Aeroqual and UV Smart, with an M&A engine described as revamped.
- Refinancing
- May 2026 issue of $600 million of 2031 notes and $500 million of 2036 notes; repaid the $900 million 3.15% notes.
Challenges and risks
- Healthcare capital spending
- AHS volume declined in 2025 on reduced demand for sterilization equipment and biomedical test products after healthcare policy changes; U.S. hospital capital spending is "still somewhat constrained".
- Tariffs and trade policy
- Tariffs, the uncertain status of IEEPA refunds and new tariffs under other authorities are flagged risks.
- Reduced U.S. government spending
- Reduced U.S. government spending under the One Big Beautiful Bill Act is a named risk.
- Low-cost competitors and input costs
- Competition is increasing from low-cost entrants, and inflation rose on electrical and electronic components and freight.
- Debt
- Total debt principal was $3,532.0 million at October 2, 2026, with leverage of 2.6x gross debt to adjusted EBITDA.
What leadership says
“Q3 marked our fifth consecutive quarter of strong execution and sequential core growth acceleration as we advance our Fortive Accelerated strategy.”
“the work we're doing this year is to set up AHS for a great run of multiyear acceleration in growth and margin expansion”
“we have revamped our M&A engine completely”
“we really see that as a meaningful acceleration for what we do in software”
Where a supplier can help
- Data-center go-to-market
- Fluke's data-center push, with added sales capacity aimed at hyperscalers and construction firms, fits sales intelligence, partner and channel providers.
- AI features for software brands
- AI agents and asset recognition at ServiceChannel and voice documentation at Provation need AI infrastructure, data and model partners.
- AHS commercial expansion
- Investments in ambulatory surgical centers and the installed base create demand for healthcare sales, service and customer-success tools.
- Supply chain cost control
- Rising electronic component and freight costs plus tariff uncertainty favor sourcing, logistics and trade-compliance suppliers.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Fortive?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Fortive Corporation Annual Report on Form 10-K for fiscal year 2025
- Fortive is an Everett, Washington-based maker of instrumentation, software and services for safety and productivity, with more than 10,000 people in approximately 50 countries; after spinning off its Precision Technologies segment as Ralliant on June 28, 2025, it reports two segments: Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS).
- FY2025 sales from continuing operations were $4,159.1 million, up 1.9% reported and 1.7% core (pricing +2.2%, volume -0.6%); operating profit margin was 17.3% versus 17.6% in 2024.
- IOS (Fluke, ServiceChannel, Gordian, Accruent, Industrial Scientific, Intelex) had sales of $2,856.3 million with a 25.8% operating margin; AHS (ASP, Censis, Fluke Biomedical, Landauer, Provation) had $1,302.8 million with a 10.6% margin.
- Approximately 44% of sales came from outside the United States; North America sales were $2,491.1 million, Asia-Pacific $730.1 million, EMEA $725.8 million and Latin America $212.1 million.
- Net earnings from continuing operations were $532.7 million ($1.59 diluted EPS); operating cash flow from continuing operations was $1,035.7 million and capex $105.1 million.
- Capital went mostly to buybacks: 30 million shares repurchased for about $1.61 billion in 2025, funded in part by a $1.15 billion cash dividend received from Ralliant; dividend is $0.06 per quarter.
- Strategy is "Fortive Accelerated": profitable organic growth acceleration powered by the Fortive Business System (FBS), disciplined capital allocation and building investor trust, with AI and machine learning added to FBS.
- AHS volume declined on reduced demand for sterilization equipment and biomedical test products due to recent changes in healthcare policy; tariffs, the IEEPA ruling, OBBBA-related cuts in U.S. government spending and about $3.2 billion of long-term debt are flagged risks.
- New leadership: Olumide Soroye became President and CEO in June 2025 and Mark Okerstrom CFO in March 2025.
- Fortive Corporation Quarterly Report on Form 10-Q for the quarter ended October 2, 2026 (Q3 2026)
- Q3 2026 sales were $1,107.5 million, up 7.8% reported and 7.2% core (pricing +2.3%, volume +4.9%); nine-month sales $3,273.7 million, up 7.8% reported and 6.4% core.
- IOS sales $767.1 million (+9.8% reported, +9.1% core), operating margin 29.1% (+320 bps), led by professional instrumentation, facilities and asset lifecycle software and gas detection.
- AHS sales $340.4 million (+3.7% reported, +3.1% core), operating margin 11.2% (-170 bps) on product mix, higher employee costs and inflation; demand driven by sterilization products.
- Group operating margin 21.3% versus 15.5%, helped by lapping 2025 separation stock compensation (+370 bps) and IEEPA tariff refunds (+160 bps); refunds recognized were $18.0 million in Q3 and $22.5 million year to date.
- Q3 net earnings from continuing operations $172.5 million, diluted EPS $0.57; nine-month operating cash flow $832.4 million.
- Year to date Fortive repurchased 17.2 million shares for about $1.0 billion, issued $1.1 billion of 2031 and 2036 notes, repaid the $900 million 3.15% notes and $293 million euro notes; debt principal $3,532.0 million.
- In June 2026 it bought a majority stake in a bolt-on AHS business for €51 million (about $58 million).
- All regions grew; risks flagged include Middle East and Ukraine conflicts, tariffs and the uncertain status of tariff refunds, and reduced U.S. government spending.
- Fortive Reports Third Quarter 2026 Results (earnings release, Exhibit 99.1)
- Q3 2026 revenue $1,108M, up 7.8% reported and 7.2% core; adjusted EBITDA $339M (+9.5%), margin 30.6% (+50 bps).
- GAAP diluted EPS $0.57 (+62.9%); adjusted diluted EPS $0.77 (+13.2%), the fifth consecutive quarter of double-digit adjusted EPS growth.
- IOS revenue $767M (+9.8% reported, +9.1% core), adjusted EBITDA margin 35.8% (+120 bps); AHS revenue $340M (+3.7% / +3.1%), adjusted EBITDA margin 25.8% (-230 bps).
- Free cash flow $284M in the quarter and $1,062M trailing twelve months; GAAP operating cash flow $313M.
- About $300M of buybacks in Q3 (~5 million shares); ~$2.3 billion repurchased since the launch of new Fortive, about 43 million shares or ~13% of shares outstanding.
- FY2026 adjusted EPS guidance raised to $3.10-$3.14, up ~15% at the midpoint.
- CEO Olumide Soroye says Fortive remains "fully confident" in the medium-term financial framework from its last Investor Day.
- Fortive Q3 2026 earnings call transcript
- Soroye calls Q3 the "fifth consecutive quarter of strong execution and sequential core growth acceleration": core revenue growth of 7.2%, adjusted EPS growth of 13%, and $2.3 billion of buybacks since the launch of new Fortive (13% of shares outstanding).
- FY2026 adjusted EPS guidance raised to $3.10-$3.14; Okerstrom now expects reported revenue "just north of $4.4 billion" and core growth "just north of 5%", ahead of the 3%-4% medium-term framework.
- IOS core growth accelerated to 9%, with Fluke, facility and asset lifecycle software (ServiceChannel, Gordian) and gas detection all close to that pace; Fluke book-to-bill stayed above 1.
- Data centers are a priority for Fluke: still "low single digits" of Fortive revenue, with deep discovery with hyperscalers and a bigger specialized sales team.
- AHS grew 3.1% core in Q3 and 4.5% year to date; 2026 is a year of "deliberate and time-bounded investments" in installed base, ambulatory surgical centers and innovation.
- AI is being embedded in software: AI-powered asset recognition and agents at ServiceChannel, iNet Insights at Industrial Scientific, voice documentation at Provation.
- Capital allocation: buybacks have dominated, but the M&A engine has been "revamped" for bolt-ons such as Aeroqual and UV Smart; dividend raised 17%; leverage 2.6x gross debt to adjusted EBITDA.
- Fortive Q4 2025 earnings call transcript
- First full-year report of "new Fortive": Q4 core growth just over 3%, adjusted EBITDA +8%, adjusted EPS +13% ($0.90); FY2025 adjusted EPS $2.71, above the $2.63-$2.67 guidance.
- Strategy: "Fortive Accelerator" with three pillars - accelerate profitable organic growth, allocate capital with discipline, build and maintain investor trust - aiming at "benchmark-beating shareholder returns".
- Initial 2026 guidance: adjusted EPS $2.90-$3.00, reported revenue of nearly $4.3 billion, core growth of 2%-3%, 50-100 bps EBITDA margin expansion.
- Buybacks: $1.3 billion in the second half of 2025, about 26 million shares or roughly 8% of diluted shares in 2025; leverage 2.6x gross debt to adjusted EBITDA.
- IOS core growth about 4% with adjusted EBITDA margin just over 37%; Fluke launched the CertiFiber Max data center tester and grew double-digit ARR in recurring revenue.
- AHS (+1.6% core) was hit by deferred U.S. hospital capital spending after reimbursement and funding policy changes; Q4 margin pressure came from localized growth investments.
- Soroye sees AI as "a meaningful acceleration" for Fortive's mission-critical software, and says the plan "does not require us to do anything dramatic from an M&A point of view".
Questions about Fortive
What does Fortive do?
Fortive designs and sells instruments, software and services for safety and productivity, including Fluke test tools, facility and asset lifecycle software, gas detection and healthcare sterilization and software products.
What is Fortive's revenue?
FY2025 sales from continuing operations were $4,159.1 million. Fortive expects FY2026 reported revenue "just north of $4.4 billion".
How many employees does Fortive have?
More than 10,000 people in approximately 50 countries.
Who leads Fortive?
Olumide Soroye has been President and CEO since June 2025 and Mark Okerstrom CFO since March 2025.
What is Fortive's strategy?
Fortive Accelerated: faster profitable organic growth through the Fortive Business System, disciplined capital allocation with large buybacks and bolt-on M&A, and building investor trust.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)